Showing results (1851-1860 of 2,046) with videos related to
Sort By:
Pageof 205
The Lancet. Oncology|March 8, 2016
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trialMassimo Cristofanilli, Nicholas C Turner, Igor Bondarenko, et al.Science Translational Medicine|November 13, 2015
Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancerGaia Schiavon, Sarah Hrebien, Isaac Garcia-Murillas, et al.Journal of Wildlife Diseases|November 15, 2021
AUSTWICKIA CHELONAE IN A WILD GOPHER TORTOISE (GOPHERUS POLYPHEMUS) AND EVIDENCE OF POSITIVE SELECTION ON THE DIPHTHERIA-LIKE TOXIN GENEBrittany L Liguori, Robert J Ossiboff, Nicole I Stacy, et al.Clinical Nutrition (Edinburgh, Scotland)|September 10, 2022
The association between maternal ultra-processed food consumption during pregnancy and child neuropsychological development: A population-based birth cohort studyJúlia Puig-Vallverdú, Dora Romaguera, Sílvia Fernández-Barrés, et al.Proceedings of the National Academy of Sciences of the United States of America|January 9, 2023
Tropical forests post-logging are a persistent net carbon source to the atmosphereMaria B Mills, Yadvinder Malhi, Robert M Ewers, et al.European Journal of Cancer (Oxford, England : 1990)|October 26, 2018
Quality of life with talazoparib after platinum or multiple cytotoxic non-platinum regimens in patients with advanced breast cancer and germline BRCA1/2 mutations: patient-reported outcomes from the ABRAZO phase 2 trialS A Hurvitz, R G W Quek, N C Turner, et al.Neurosurgical Focus|May 1, 2023
The first decade of flow diversion for intracranial aneurysms with the Pipeline embolization deviceAndre Monteiro, Jaims Lim, Manhal Siddiqi, et al.The Lancet Regional Health. Europe|July 4, 2025
Occupational health in the era of climate change and the green transition: a call for researchMichelle C Turner, Xavier Basagaña, Maria Albin, et al.Clinical Pharmacology and Therapeutics|September 27, 2024
A Novel Step-Up Dosage Regimen for Enhancing the Benefit-to-Risk Ratio of Mosunetuzumab in Relapsed or Refractory Follicular LymphomaChi-Chung Li, Brendan Bender, Justin Wilkins, et al.Diabetes|March 1, 1997
Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4P J Kaisaki, S Menzel, T Lindner, et al.Pageof 205